Solispharmsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-01-14
Share capital
25,000.00 PLN
Registered address
Starzyńskiego 10, 03-459 Warszawa, Poland

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)-$22,522

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 77 days for 2024). 3 of 6 audited by a statutory auditor.

  • 202524/07/2026
  • 202430/09/2025
  • 202311/07/2024
  • 202221/04/2023
  • 202103/06/2022
  • 202023/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 3.2%
Division · Retail trade433 / 9,914
Top 4.4%
City · Warszawa1,897 / 56,958
Top 3.3%
Voivodeship · Mazowieckie2,558 / 77,118
Top 3.3%
Country · Poland8,509 / 297,873
Top 2.9%

Results vs industry

Revenue
This companyUSD 25.75mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -185.29kMedianUSD 20.70kAverageUSD 86.94k
Operating costs
This companyUSD 25.85mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 6.37mMedianUSD 543.65kAverageUSD 1.76m

Public procurement

67 tenders recorded as contractor: 61 national ($1,794,617) and 6 EU ($19,331,379).

SubjectAmount
Purchase and supply of medicines and medical supplies
$5,117
Supply of medical equipment, medicinal products and dressings
$46,718
Supply of medical devices divided into two lots
$128.7K

National Health Fund (NFZ) contracts

Solispharm has been an NFZ healthcare provider since 2024. In 2026 it is performing 2 contracts with a total value of USD 4.70k. All its contracts were worth USD 31.31k in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmesmazowieckie1USD 4.70k
Other services provided in pharmaciesmazowieckie1USD 0.00

Authorized Representatives

Paweł Gajewski – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Paweł Gajewskiage 45
400$5,402.4980%
Maciej Jacek Kalińskiage 52
100$1,350.6220%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2014-01-16.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 110.3K

Public aid

8 public aid cases recorded, with a total value of $300,264.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Cosmedicasp. z o.o.
DR ZdrowieS.A.
MagmaxS.A.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

Change history

DateEvent
2023-07-05PKD change
2020-02-11Share capital increase
2017-01-27PKD change
2014-01-14Entered in the register

FAQ

Last updated: 2026-08-19